表紙
市場調査レポート

糞線虫症:世界の治験レビュー

Strongyloidiasis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322159
出版日 ページ情報 英文 49 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.16円で換算しております。
Back to Top
糞線虫症:世界の治験レビュー Strongyloidiasis Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 49 Pages
概要

当レポートでは、糞線虫症の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 糞線虫症
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:感染症の治験における糞線虫症の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Johnson & Johnson
  • 代表的な研究機関・病院の治験の概要
    • The National Institute of Allergy and Infectious Diseases
    • Centers for Disease Control and Prevention
    • Universidad Nacional de Salta
    • Centro Malattie Tropicali
    • Ospedale Sacro Cuore - Don Calabria
    • Menzies School of Health Research
    • Mahidol University

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2500CTIDB

GlobalData's clinical trial report, "Strongyloidiasis Global Clinical Trials Review, H2, 2014" provides data on the Strongyloidiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Strongyloidiasis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Strongyloidiasis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Strongyloidiasis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Strongyloidiasis to Infectious Disease Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
    • Clinical Trial Overview of Top Institutes / Government
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • Centers for Disease Control and Prevention
      • Clinical Trial Overview of Centers for Disease Control and Prevention
      • Universidad Nacional de Salta
      • Clinical Trial Overview of Universidad Nacional de Salta
      • Centro Malattie Tropicali
      • Clinical Trial Overview of Centro Malattie Tropicali
      • Ospedale Sacro Cuore - Don Calabria
      • Clinical Trial Overview of Ospedale Sacro Cuore - Don Calabria
      • Menzies School of Health Research
      • Clinical Trial Overview of Menzies School of Health Research
      • Mahidol University
      • Clinical Trial Overview of Mahidol University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidad Nacional de Salta, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centro Malattie Tropicali, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Sacro Cuore - Don Calabria, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014*

List of Figures

  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Strongyloidiasis to Infectious Disease Clinical Trials, G7 Countries (%), 2014*
  • Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Strongyloidiasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Strongyloidiasis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Strongyloidiasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Strongyloidiasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top